TP53 and cancer: Moreover, selective inhibition of ribosomal gene transcription in the nucleolus has been shown to be an effective therapeutic strategy to promote cancer-specific activation of p53 (Bywater et al., 2012; Hein et al., 2013; James et al., 2014; Woods et al., 2015; Carotenuto et al., 2019).